SEOUL, South Korea--(BUSINESS WIRE)--VIOL Co., Ltd hosted the first global event called “Moonlight Sylfirm X Global Symposium 2022” on September 18th, at the Grand Mercure Hotel, Seoul. The Symposium ...
AT 430. THE FDA IS WARNING OF POTENTIAL RISKS OF A POPULAR SKINCARE TREATMENT. IT’S CALLED RADIOFREQUENCY MICRONEEDLING. THE FDA SAYS IT CAN CAUSE SERIOUS COMPLICATIONS, INCLUDING BURNS, DISFIGUREMENT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results